{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T05:03:44Z","timestamp":1762232624068,"version":"build-2065373602"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Clinics of North America"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.ucl.2025.07.001","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T11:22:32Z","timestamp":1754997752000},"page":"475-487","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Do Genetics Predict Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia?"],"prefix":"10.1016","volume":"52","author":[{"given":"Alexander P.","family":"Glaser","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianfeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian T.","family":"Helfand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib1","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S0022-5347(17)49698-4","article-title":"The development of human benign prostatic hyperplasia with age","volume":"132","author":"Berry","year":"1984","journal-title":"J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib2","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1464-410X.2009.08427.x","article-title":"The prevalence of lower urinary tract symptoms (LUTS) in the USA, the UK and Sweden: results from the Epidemiology of LUTS (EpiLUTS) study","volume":"104","author":"Coyne","year":"2009","journal-title":"BJU Int"},{"issue":"5","key":"10.1016\/j.ucl.2025.07.001_bib3","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1016\/S0022-5347(01)67448-2","article-title":"Natural history of prostatism: relationship among symptoms, prostate volume and peak urinary flow rate","volume":"153","author":"Girman","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.ucl.2025.07.001_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f2109","article-title":"Effect of dutasteride on clinical progression of benign prostatic hyperplasia in asymptomatic men with enlarged prostate: a post hoc analysis of the REDUCE study","volume":"346","author":"Toren","year":"2013","journal-title":"BMJ"},{"issue":"Suppl 3","key":"10.1016\/j.ucl.2025.07.001_bib5","doi-asserted-by":"crossref","first-page":"S11","DOI":"10.1038\/ijir.2008.55","article-title":"Pathology of benign prostatic hyperplasia","volume":"20","author":"Roehrborn","year":"2008","journal-title":"Int J Impot Res"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ajur.2017.06.003","article-title":"Pathophysiology of clinical benign prostatic hyperplasia","volume":"4","author":"Foo","year":"2017","journal-title":"Asian J Urol"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib7","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ucl.2016.04.012","article-title":"Review of prostate anatomy and embryology and the etiology of benign prostatic hyperplasia","volume":"43","author":"Aaron","year":"2016","journal-title":"Urol Clin North Am"},{"issue":"7","key":"10.1016\/j.ucl.2025.07.001_bib8","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s00345-019-02691-0","article-title":"What is a disease? What is the disease clinical benign prostatic hyperplasia (BPH)?","volume":"37","author":"Foo","year":"2019","journal-title":"World J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib9","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/bju.15229","article-title":"Benign prostatic hyperplasia - what do we know?","volume":"127","author":"Devlin","year":"2020","journal-title":"BJU Int"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ajur.2019.10.003","article-title":"The role of the androgen receptor in prostate development and benign prostatic hyperplasia: a review","volume":"7","author":"Vickman","year":"2020","journal-title":"Asian J Urol"},{"issue":"12","key":"10.1016\/j.ucl.2025.07.001_bib11","doi-asserted-by":"crossref","first-page":"4324","DOI":"10.1210\/jcem.84.12.6206","article-title":"Long-term consequences of castration in men: lessons from the Skoptzy and the eunuchs of the Chinese and Ottoman courts","volume":"84","author":"Wilson","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ucl.2025.07.001_bib12","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM198709033171004","article-title":"The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia","volume":"317","author":"Peters","year":"1987","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib13","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1210\/jc.2005-1947","article-title":"Relationship among serum testosterone, sexual function, and response to treatment in men receiving dutasteride for benign prostatic hyperplasia","volume":"91","author":"Marberger","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.ucl.2025.07.001_bib14","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nrurol.2016.168","article-title":"Inflammatory mediators in the development and progression of benign prostatic hyperplasia","volume":"13","author":"De Nunzio","year":"2016","journal-title":"Nat Rev Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.001_bib15","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.juro.2015.03.103","article-title":"Prostate biopsy markers of inflammation are associated with risk of clinical progression of benign prostatic hyperplasia: findings from the MTOPS study","volume":"194","author":"Torkko","year":"2015","journal-title":"J Urol"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.001_bib16","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.eururo.2007.11.026","article-title":"The relationship between prostate inflammation and lower urinary tract symptoms: examination of baseline data from the REDUCE trial","volume":"54","author":"Nickel","year":"2008","journal-title":"Eur Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.001_bib17","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41467-022-29719-1","article-title":"TNF is a potential therapeutic target to suppress prostatic inflammation and hyperplasia in autoimmune disease","volume":"13","author":"Vickman","year":"2022","journal-title":"Nat Commun"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.euf.2023.10.015","article-title":"Effect of TNF-\u03b1 inhibitor therapy on growth of the prostate gland","volume":"10","author":"Al-Faouri","year":"2023","journal-title":"European Urology Focus"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2023.103511","article-title":"Benign prostatic hyperplasia - a novel autoimmune disease with a potential therapy consequence?","volume":"23","author":"Liedtke","year":"2023","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib20","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s11934-996-0008-y","article-title":"Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"7","author":"Kasturi","year":"2006","journal-title":"Curr Urol Rep"},{"issue":"4 Pt 1","key":"10.1016\/j.ucl.2025.07.001_bib21","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1097\/01.ju.0000173072.73702.64","article-title":"Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia","volume":"174","author":"McVary","year":"2005","journal-title":"J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.001_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/JU.0000000000002493","article-title":"Impact of sleep disturbance, physical function, depression and anxiety on male lower urinary tract symptoms: results from the symptoms of lower urinary tract dysfunction research network (LURN)","volume":"208","author":"Glaser","year":"2022","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.001_bib23","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.juro.2018.02.075","article-title":"Prevalence and characteristics of urinary incontinence in a treatment seeking male prospective cohort: results from the LURN study","volume":"200","author":"Helfand","year":"2018","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib24","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.urology.2006.04.019","article-title":"Prevalence, severity, and health correlates of lower urinary tract symptoms among older men: the MrOS study","volume":"68","author":"Taylor","year":"2006","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.001_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.urology.2012.04.004","article-title":"Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS","volume":"80","author":"Milsom","year":"2012","journal-title":"Urology"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.001_bib26","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1111\/bju.15286","article-title":"The rising worldwide impact of benign prostatic hyperplasia","volume":"127","author":"Launer","year":"2021","journal-title":"BJU Int"},{"key":"10.1016\/j.ucl.2025.07.001_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.urology.2016.07.028","article-title":"Projecting the urology workforce over the next 20 years","volume":"98","author":"McKibben","year":"2016","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.urology.2012.12.004","article-title":"Challenges facing academic urology training programs: an impending crisis","volume":"81","author":"Gonzalez","year":"2013","journal-title":"Urology"},{"year":"2025","series-title":"Our priority","key":"10.1016\/j.ucl.2025.07.001_bib29"},{"year":"2023","series-title":"UDA Data Report: epidemiology of non-malignant urologic disease in the United States","key":"10.1016\/j.ucl.2025.07.001_bib30"},{"issue":"5","key":"10.1016\/j.ucl.2025.07.001_bib31","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0090-4295(94)80197-5","article-title":"Concordance rates for benign prostatic disease among twins suggest hereditary influence","volume":"44","author":"Partin","year":"1994","journal-title":"Urology"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.001_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0022-5347(17)32831-8","article-title":"Genetic susceptibility of benign prostatic hyperplasia","volume":"152","author":"Sanda","year":"1994","journal-title":"J Urol"},{"issue":"9","key":"10.1016\/j.ucl.2025.07.001_bib33","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/oxfordjournals.aje.a117745","article-title":"Association between family history of benign prostatic hyperplasia and urinary symptoms: results of a population-based study","volume":"142","author":"Roberts","year":"1995","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ede.0000219723.14476.28","article-title":"Concordance rates and modifiable risk factors for lower urinary tract symptoms in twins","volume":"17","author":"Rohrmann","year":"2006","journal-title":"Epidemiology"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib35","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1002\/pros.23737","article-title":"Prevalence and heritability of benign prostatic hyperplasia and LUTS in men aged 40 years or older in Zhengzhou rural areas","volume":"79","author":"Yue","year":"2019","journal-title":"Prostate"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.001_bib36","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/bju.16517","article-title":"Inheritance patterns of lower urinary tract symptoms in adults: a systematic review","volume":"135","author":"Moore","year":"2025","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.001_bib37","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1016\/j.eururo.2011.03.007","article-title":"Genetic influences are important for most but not all lower urinary tract symptoms: a population-based survey in a cohort of adult Swedish twins","volume":"59","author":"Wennberg","year":"2011","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib38","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S0090-4295(98)00569-X","article-title":"Heritability of the symptoms of benign prostatic hyperplasia and the roles of age and zonal prostate volumes in twins","volume":"53","author":"Meikle","year":"1999","journal-title":"Urology"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0090-4295(02)02509-8","article-title":"Familial aggregation of bothersome benign prostatic hyperplasia symptoms","volume":"61","author":"Pearson","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.ucl.2025.07.001_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.urology.2019.04.005","article-title":"Genetic and environmental influences on urinary conditions in men: a classical twin study","volume":"129","author":"Gasperi","year":"2019","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.ucl.2025.07.001_bib41","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1016\/j.juro.2016.06.018","article-title":"Heritability of lower urinary tract symptoms in men: a twin study","volume":"196","author":"Afari","year":"2016","journal-title":"J Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib42","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1530\/eje.0.1470479","article-title":"Impact of constitutional genetic variation in androgen\/oestrogen-regulating genes on age-related changes in human prostate","volume":"147","author":"Azzouzi","year":"2002","journal-title":"Eur J Endocrinol"},{"issue":"5","key":"10.1016\/j.ucl.2025.07.001_bib43","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1464-410X.2008.07667.x","article-title":"Genetic polymorphism and pathogenesis of benign prostatic hyperplasia","volume":"102","author":"Konwar","year":"2008","journal-title":"BJU Int"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.001_bib44","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1476-5381.1996.tb15552.x","article-title":"Alpha 1a-adrenoceptor polymorphism: pharmacological characterization and association with benign prostatic hypertrophy","volume":"118","author":"Shibata","year":"1996","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib45","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1093\/aje\/kwh042","article-title":"Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia","volume":"159","author":"Roberts","year":"2004","journal-title":"Am J Epidemiol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib46","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/pros.20142","article-title":"Polymorphisms in the 5alpha reductase type 2 gene and urologic measures of BPH","volume":"62","author":"Roberts","year":"2005","journal-title":"Prostate"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib47","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.urolonc.2004.12.014","article-title":"Associations between polymorphisms in the steroid 5-alpha reductase type II (SRD5A2) gene and benign prostatic hyperplasia and prostate cancer","volume":"23","author":"Salam","year":"2005","journal-title":"Urol Oncol"},{"issue":"11","key":"10.1016\/j.ucl.2025.07.001_bib48","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3390\/ijerph14111318","article-title":"Molecular analysis of the SRD5A1 and SRD5A2 genes in patients with benign prostatic hyperplasia with regard to metabolic parameters and selected hormone levels","volume":"14","author":"Ryl","year":"2017","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.001_bib49","first-page":"305","article-title":"Association of vitamin D receptor gene polymorphism with prostate cancer and benign prostatic hyperplasia in a Japanese population","volume":"60","author":"Habuchi","year":"2000","journal-title":"Cancer Res"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.001_bib50","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000020124","article-title":"Polymorphisms in the vitamin D receptor gene and the androgen receptor gene and the risk of benign prostatic hyperplasia","volume":"37","author":"Bousema","year":"2000","journal-title":"Eur Urol"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib51","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1159\/000058440","article-title":"Significance of vitamin D receptor gene polymorphism for risk and disease severity of prostate cancer and benign prostatic hyperplasia in Japanese","volume":"68","author":"Hamasaki","year":"2002","journal-title":"Urol Int"},{"issue":"4","key":"10.1016\/j.ucl.2025.07.001_bib52","first-page":"447","article-title":"Vitamin D receptor, HER-2 polymorphisms and risk of prostate cancer in men with benign prostate hyperplasia","volume":"25","author":"Tayeb","year":"2004","journal-title":"Saudi Med J"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.001_bib53","first-page":"136","article-title":"Lack of association of VDR polymorphisms with Thai prostate cancer as compared with benign prostate hyperplasia and controls","volume":"7","author":"Chaimuangraj","year":"2006","journal-title":"Asian Pac J Cancer Prev"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.001_bib54","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/sj.bjc.6600825","article-title":"CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia","volume":"88","author":"Tayeb","year":"2003","journal-title":"Br J Cancer"},{"issue":"5","key":"10.1016\/j.ucl.2025.07.001_bib55","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/path.999","article-title":"Localization of angiotensin-converting enzyme in the human prostate: pathological expression in benign prostatic hyperplasia","volume":"195","author":"Nassis","year":"2001","journal-title":"J Pathol"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.001_bib56","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13643-022-01914-7","article-title":"Systematic review and meta-analysis of candidate gene association studies of benign prostate hyperplasia","volume":"11","author":"Lin","year":"2022","journal-title":"Syst Rev"},{"issue":"7837","key":"10.1016\/j.ucl.2025.07.001_bib57","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2830-7","article-title":"PIEZO2 in sensory neurons and urothelial cells coordinates urination","volume":"588","author":"Marshall","year":"2020","journal-title":"Nature"},{"issue":"7726","key":"10.1016\/j.ucl.2025.07.001_bib58","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41586-018-0579-z","article-title":"The UK Biobank resource with deep phenotyping and genomic data","volume":"562","author":"Bycroft","year":"2018","journal-title":"Nature"},{"issue":"Supplement 4","key":"10.1016\/j.ucl.2025.07.001_bib59","doi-asserted-by":"crossref","DOI":"10.1097\/JU.0000000000003249.12","article-title":"MP24-12 Association of rare monogenic variants wtih diagnosis of BPH using whole exome sequencing in the UK Biobank","volume":"209","author":"Judge","year":"2023","journal-title":"J Urol"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.001_bib60","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.ajhg.2012.06.007","article-title":"Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies","volume":"91","author":"Lee","year":"2012","journal-title":"Am J Hum Genet"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib61","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.juro.2012.11.044","article-title":"Genetic sequence variants are associated with severity of lower urinary tract symptoms and prostate cancer susceptibility","volume":"189","author":"Helfand","year":"2013","journal-title":"J Urol"},{"issue":"8","key":"10.1016\/j.ucl.2025.07.001_bib62","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s00345-020-03531-2","article-title":"The effect of \u03b2(3)-adrenoceptor gene polymorphisms on lower urinary tract function in males","volume":"39","author":"Haga","year":"2021","journal-title":"World J Urol"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.001_bib63","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.1038\/s41467-018-06920-9","article-title":"Genome-wide associations for benign prostatic hyperplasia reveal a genetic correlation with serum levels of PSA","volume":"9","author":"Gudmundsson","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.001_bib64","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1038\/s41598-019-42427-z","article-title":"Heritability and genome-wide association study of benign prostatic hyperplasia (BPH) in the eMERGE network","volume":"9","author":"Hellwege","year":"2019","journal-title":"Sci Rep"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.001_bib65","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glad187","article-title":"Causal associations between lifestyle habits and risk of benign prostatic hyperplasia: a two-sample mendelian randomization study","volume":"79","author":"Jia","year":"2024","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"2","key":"10.1016\/j.ucl.2025.07.001_bib66","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/s41391-020-00303-2","article-title":"Genome-wide association study identifies a role for the progesterone receptor in benign prostatic hyperplasia risk","volume":"24","author":"Li","year":"2021","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.ucl.2025.07.001_bib67","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.1000667","article-title":"Polygenic risk scores: an overview from bench to bedside for personalised medicine","volume":"13","author":"Cross","year":"2022","journal-title":"Front Genet"},{"issue":"6","key":"10.1016\/j.ucl.2025.07.001_bib68","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ajhg.2018.03.021","article-title":"Estimation of genetic correlation via linkage disequilibrium score regression and genomic restricted maximum likelihood","volume":"102","author":"Ni","year":"2018","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.ucl.2025.07.001_bib69","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.euros.2022.07.004","article-title":"Shared inherited genetics of benign prostatic hyperplasia and prostate cancer","volume":"43","author":"Glaser","year":"2022","journal-title":"European Urology Open Science"},{"issue":"5S","key":"10.1016\/j.ucl.2025.07.001_bib70","doi-asserted-by":"crossref","DOI":"10.1097\/01.JU.0001008920.55771.18.16","article-title":"MP09-16 Does activity level modulate the genetic risk of BPH? A cohort study from the UK Biobank","volume":"221","author":"Glaser","year":"2024","journal-title":"J Urol"},{"issue":"12","key":"10.1016\/j.ucl.2025.07.001_bib71","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/pros.21348","article-title":"Reduced levels of 5-\u03b1 reductase 2 in adult prostate tissue and implications for BPH therapy","volume":"71","author":"Niu","year":"2011","journal-title":"Prostate"},{"issue":"25","key":"10.1016\/j.ucl.2025.07.001_bib72","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa030656","article-title":"The long-term effect of doxazosin, finasteride, and combination therapy on the clincial progression of benign prostatic hyperplasia","volume":"349","author":"McConnell","year":"2003","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ucl.2025.07.001_bib73","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/bju.13033","volume":"116","author":"Roehrborn","year":"2015","journal-title":"BJU Int"},{"issue":"1","key":"10.1016\/j.ucl.2025.07.001_bib74","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1464-410X.2012.11287.x","article-title":"Association between physical activity, lower urinary tract symptoms (LUTS) and prostate volume","volume":"111","author":"Fowke","year":"2013","journal-title":"BJU Int"}],"container-title":["Urologic Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0094014325000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T05:00:47Z","timestamp":1762232447000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0094014325000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0094014325000564"],"URL":"https:\/\/doi.org\/10.1016\/j.ucl.2025.07.001","relation":{},"ISSN":["0094-0143"],"issn-type":[{"type":"print","value":"0094-0143"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do Genetics Predict Lower Urinary Tract Symptoms and Benign Prostatic Hyperplasia?","name":"articletitle","label":"Article Title"},{"value":"Urologic Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ucl.2025.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}